Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J. Bras. Patol. Med. Lab. (Online) ; 58: e4492022, 2022. graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1375704

RESUMO

ABSTRACT Male patient, 68 years old, immunocompromised, presented himself with fever and malaise for 15 days. At his hospitalization, peripheral blood and Schilley catheter blood cultures were collected, in addition to computed tomography that showed the presence of a peri-pancreatic collection. The material was drained and the samples were sent to the laboratory. Blood culture was positive for pink coconuts identified by mass spectrometry as Roseomonas spp. with the diagnosis of Bloodstream Infection being closed.

2.
Arq. bras. med. vet. zootec ; 67(6): 1554-1562, nov.-dez. 2015. graf
Artigo em Português | LILACS | ID: lil-768152

RESUMO

Objetivou-se com este estudo avaliar o efeito analgésico trans e pós-operatório da eletroacupuntura em onda denso-dispersa e frequências 3 e 200Hz, nos pontos E44, R3 e BP4, compará-lo com a analgesia promovida pelos pontos BP6, E36 e VB 34, e pela morfina, em cadelas submetidas à ovariosalpingohisterectomia (OSH). Teve-se como hipótese que a eletroacupuntura nos pontos E44, R3 e BP4 resultaria em controle da dor trans e pós-operatória melhor ou igual àquele promovido pela eletroacupuntura nos pontos BP6, E36 e VB34 e pela morfina. Trinta e seis cadelas submetidas à cirurgia eletiva de OSH foram distribuídas em blocos ao acaso em três grupos com 12 animais. Em dois grupos foi realizada eletroacupuntura denso-dispersa, com frequência de 3 e 200Hz, sendo que, no primeiro grupo (GEA), foram estimulados os pontos BP4, E44, R3 e, no segundo grupo (GEB), os pontos BP6, E36, VB34...


Thirty-six dogs undergoing elective ovariohysterectomy surgery were randomly distributed into 3 groups of 12 animals each. In the first group, dense-dispersed electroacupuncture was performed with a frequency of 3-200 Hz in SP4, ST44, KID3 points and 1.5mL of saline was given intramuscularly (GEA group). For the second group, dense-dispersed electroacupuncture was performed with a frequency of 3-200 Hz in SP6, ST36, GB34 points and 1.5mL of saline given intramuscularly (GEB group)...


Assuntos
Animais , Feminino , Cães , Analgesia por Acupuntura/veterinária , Eletroacupuntura , Eletroacupuntura/veterinária , Histerectomia/veterinária , Ovariectomia/veterinária , Estimulação Elétrica Nervosa Transcutânea/veterinária , Morfina/administração & dosagem , Período Pós-Operatório
3.
AIDS ; 11(12): 1433-44, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9342065

RESUMO

OBJECTIVE: To develop a putative immunization cassette using HIV-1 vif accessory gene derived from HIV-1 clinical specimens as a component of a DNA vaccine for HIV-1. METHODS: vif genes were cloned from HIV-1-infected patients and the sequence variation present within the patients was analyzed. Prototypic genetic variants were selected and the ability of these clones to induce humoral and cellular immune responses was studied in animals. The selected protective genetic variants were biologically characterized through transcomplementation assays using primary cells infected with a vif-defective HIV-1 proviral clone. RESULTS: Analysis of vif variants from different patients revealed that vif is highly conserved with the open reading frame remaining intact in vivo. It was shown that attenuated vif clones from HIV-1-infected subjects can effectively induce both humoral and cellular responses against Vif protein in mice. Evaluation of the cellular responses in vitro using human cellular targets infected with a clinical HIV-1 isolate showed that vif clones could induce cellular responses capable of destroying the virus. CONCLUSIONS: The vif variants developed in this study exhibited non-productive phenotypes, yet were capable of inducing specific immune responses against HIV-1. These constructs could be used as part of a DNA vaccine strategy for HIV-1. This vaccine adaptation strategy could be used for the development of immunogens for any pathogen resulting in cross-reactive immunity and attenuated gene pathogenesis.


Assuntos
Vacinas contra a AIDS/genética , Produtos do Gene vif/genética , Vacinas de DNA , Sequência de Aminoácidos , Animais , Clonagem Molecular , DNA Viral/imunologia , Expressão Gênica , Produtos do Gene vif/imunologia , Anticorpos Anti-HIV/análise , Infecções por HIV/prevenção & controle , HIV-1 , Humanos , Camundongos , Dados de Sequência Molecular , Mutagênese Insercional , Plasmídeos/metabolismo , Análise de Sequência de DNA , Células Tumorais Cultivadas , Vacinas Atenuadas/genética , Vacinas de DNA/genética , Produtos do Gene vif do Vírus da Imunodeficiência Humana
4.
DNA Cell Biol ; 15(7): 571-80, 1996 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8756338

RESUMO

To obtain insight into the factors involved in vertical transmission, we compared the sequence diversity, seroreactivity, and biological characteristics of human immunodeficiency virus type 1 (HIV-1) derived from a transmitter and nontransmitter mother pair. Forty-two clones from the transmitter and 20 from the nontransmitter, spanning the principal neutralization determinant (PND) of the env gene, were sequenced and analyzed. The intrapatient sequence variation in transmitter and nontransmitter viruses was 12% and 36%, respectively, and the interpatient variation was 38%. In an effort to correlate immune responses to viral genetics, we analyzed the sera from these patients against a number of V3 peptides from known HIV-1 isolates. We observed that (i) both the transmitter and nontransmitter sera demonstrated higher binding to V3 peptides based on SF-2 and MN sequences than to IIIB and Z6 isolates; (ii) the vertical transmission of HIV-1 is correlated with the absence of high maternal antibody responses to the PND; and (iii) the high-affinity binding of the sera to SF-2 and MN V3 peptides correlated with the sequence analysis, indicating that the V3 sequences from both patients are more closely related to ADA, SF-162, and MN than to IIIB or Z6. Biological analysis of the viruses from these patients demonstrate that the transmitters' viruses infect a number of T-cell lines in vitro, whereas the nontransmitter viruses do not infect cell lines or the primary lymphocytes.


Assuntos
Heterogeneidade Genética , Antígenos HIV/genética , Infecções por HIV/transmissão , HIV-1/genética , Transmissão Vertical de Doenças Infecciosas , Sequência de Aminoácidos , Sequência de Bases , Clonagem Molecular , Epitopos , Feminino , Anticorpos Anti-HIV/sangue , Proteína gp120 do Envelope de HIV/genética , HIV-1/classificação , Humanos , Dados de Sequência Molecular , Filogenia , Estrutura Secundária de Proteína , Análise de Sequência de DNA , Homologia de Sequência de Aminoácidos
5.
Cell ; 72(4): 541-50, 1993 Feb 26.
Artigo em Inglês | MEDLINE | ID: mdl-8440020

RESUMO

Cell lines from rhabdomyosarcomas, which are tumors of muscle origin, have been used as models of CD4-independent HIV infection. These cell lines can be induced to differentiate in vitro. We report here that the vpr gene of HIV1 is sufficient for the differentiation of the human rhabdomyosarcoma cell line TE671. Differentiated cells are characterized by great enlargement, altered morphology, lack of replication, and high level expression of the muscle-specific protein myosin. We have also observed the morphological differentiation and inhibition of proliferation of two other transformed cell lines. vpr-transfected cells remain fully viable in culture for extended periods. These observations elucidate a potential role for vpr in the virus life cycle and raise the possibility that some aspects of HIV-induced pathologies may be caused by a disturbance of cells by vpr.


Assuntos
Diferenciação Celular , Produtos do Gene vpr/fisiologia , Genes vpr , Infecções por HIV/patologia , HIV-1/patogenicidade , Expressão Gênica , HIV-1/genética , Humanos , Miosinas/genética , Osteossarcoma/patologia , Rabdomiossarcoma/patologia , Deleção de Sequência , Células Tumorais Cultivadas , Produtos do Gene vpr do Vírus da Imunodeficiência Humana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA